65
Views
19
CrossRef citations to date
0
Altmetric
Special Report

The red skin syndromes: corticosteroid addiction and withdrawal

&
Pages 547-561 | Published online: 10 Jan 2014
 

Abstract

Chronic, worsening eczematous rash patients are frequently tested and re-evaluated to search for a cause, since they appear to resist treatment with corticosteroids. The patients are usually atopics. Systemic evaluations and various allergy testing coupled with a large variety of topical and systemic medications fail to manage the problem. Typically, the patients initially experience a minimal rash that progresses to a more extensive markedly symptomatic dermatitis despite increasing amounts and strengths of topical and systemic steroids. Various syndromes have been named depending upon the body location involved. In evaluating and treating over 1500 patients it has been ascertained that the worsening problem is due to the therapy, namely corticosteroids, not uncontrollable eczema. Cure occurred in all patients after total cessation of these medications, requiring at times 1–2 years attended by multiple flares of the rash. The mechanism appears to be vascular nitric oxide release. This article delineates in minute detail the typical patterns of addiction, the total evaluation of the patients and the characteristic events of prolonged withdrawal. A study of serum nitric oxide values is included to help in understanding this frequently perplexing disease.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access
  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 99.00 Add to cart
* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.